Xtrackers S&P Dividend Aristocrats Screened ETF
SNPD · ETF
About SNPD
- Issuer
- Xtrackers
- Tracks
- S&P High Yield Dividend Aristocrats Screened Index
- Expense ratio
- 0.15%
- Assets under management
- $3.28M
- Inception
- Nov 9, 2022
- Asset class
- Equity
- Website
- etf.dws.com
SNPD key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 1.20K
- Volume
- 51
- Open price
- $30.65
- High today
- $30.63
- Low today
- $30.63
- 52 Week high
- $31.32
- 52 Week low
- $26.12
Xtrackers S&P Dividend Aristocrats Screened ETF (SNPD) at a glance
Xtrackers S&P Dividend Aristocrats Screened ETF (SNPD) last traded at $30.63, with a market cap of 0 and a price-to-earnings ratio of 0.00.
Volume so far is 51 shares, below the average of 1.20K shares a day.
Over the past year Xtrackers S&P Dividend Aristocrats Screened ETF has ranged from $26.12 to $31.32, and now sits 87% of the way up that range.
SNPD news
- Lekha Gupta
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.